Defective lysosomal exocytosis and plasma membrane repair in Chediak-Higashi/beige cells

被引:116
作者
Huynh, C
Roth, D
Ward, DM
Kaplan, J
Andrews, NW
机构
[1] Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, New Haven, CT 06536 USA
[2] Yale Univ, Sch Med, Dept Cell Biol, Boyer Ctr Mol Med, New Haven, CT 06536 USA
[3] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA
关键词
lysosome; injury; resealing;
D O I
10.1073/pnas.0405905101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Plasma membrane resealing is a Ca2+-dependent process that involves the exocytosis of intracellular vesicles next to the wound site. Recent studies revealed that conventional lysosomes behave as Ca2+-regulated secretory compartments and play a central role in membrane resealing. These findings raised the possibility that the complex pathology of lysosomal diseases might also include defects in plasma membrane repair. Here, we investigated the capacity for lysosomal exocytosis and membrane resealing of fibroblasts derived from Chediak-Higashi syndrome (CHS) patients, or from beige-J mice. By using a sensitive electroporation/fluorescence-activated cell sorter-based assay, we show that lysosomal exocytosis triggered by membrane wounding is impaired in both human Chediak-Higashi and mouse beige-J fibroblasts. Lysosomal exocytosis increased when the normal size of lysosomes was restored in beige-J cells by expression of the CHS/Beige protein. A similar effect was seen when the lysosomal enlargement in beige-J cells was reversed by treatment with E64d. In addition, the survival of Chediak-Higashi and beige-J fibroblasts after wounding was reduced, indicating that impaired lysosomal exocytosis inhibits membrane resealing in these mutant cells. Thus, the severe symptoms exhibited by CHS patients may also include defects in the ability of cells to repair plasma membrane lesions.
引用
收藏
页码:16795 / 16800
页数:6
相关论文
共 32 条
[1]   Regulated secretion of conventional lysosomes [J].
Andrews, NW .
TRENDS IN CELL BIOLOGY, 2000, 10 (08) :316-321
[2]  
BAETZ K, 1995, J IMMUNOL, V154, P6122
[3]   DEFECTIVE LYSOSOMAL ENZYME-SECRETION IN KIDNEYS OF CHEDIAK-HIGASHI (BEIGE) MICE [J].
BRANDT, EJ ;
ELLIOTT, RW ;
SWANK, RT .
JOURNAL OF CELL BIOLOGY, 1975, 67 (03) :774-788
[4]   Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice [J].
Chakrabarti, S ;
Kobayashi, KS ;
Flavell, RA ;
Marks, CB ;
Miyake, K ;
Liston, DR ;
Fowler, KT ;
Gorelick, FS ;
Andrews, NW .
JOURNAL OF CELL BIOLOGY, 2003, 162 (04) :543-549
[5]   ELECTROPORATION FOR THE EFFICIENT TRANSFECTION OF MAMMALIAN-CELLS WITH DNA [J].
CHU, G ;
HAYAKAWA, H ;
BERG, P .
NUCLEIC ACIDS RESEARCH, 1987, 15 (03) :1311-1326
[6]   Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome [J].
Faigle, W ;
Raposo, G ;
Tenza, D ;
Pinet, V ;
Vogt, AB ;
Kropshofer, H ;
Fischer, A ;
de Saint-Basile, G ;
Amigorena, S .
JOURNAL OF CELL BIOLOGY, 1998, 141 (05) :1121-1134
[7]   INTRODUCTION OF UNLABELED PROTEINS INTO LIVING CELLS BY ELECTROPORATION AND ISOLATION OF VIABLE PROTEIN-LOADED CELLS USING DEXTRAN FLUORESCEIN ISOTHIOCYANATE AS A MARKER FOR PROTEIN-UPTAKE [J].
GRAZIADEI, L ;
BURFEIND, P ;
BARSAGI, D .
ANALYTICAL BIOCHEMISTRY, 1991, 194 (01) :198-203
[8]   TREATMENT OF CHEDIAK-HIGASHI-SYNDROME BY ALLOGENIC BONE-MARROW TRANSPLANTATION - REPORT OF 10 CASES [J].
HADDAD, E ;
LEDEIST, F ;
BLANCHE, S ;
BENKERROU, M ;
ROHRLICH, P ;
VILMER, E ;
GRISCELLI, C ;
FISCHER, A .
BLOOD, 1995, 85 (11) :3328-3333
[9]   CHEDIAK-HIGASHI GENE IN HUMANS .1. IMPAIRMENT OF NATURAL-KILLER FUNCTION [J].
HALIOTIS, T ;
RODER, J ;
KLEIN, M ;
ORTALDO, J ;
FAUCI, AS ;
HERBERMAN, RB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 151 (05) :1039-1048
[10]   Synaptotagmin VII restricts fusion pore expansion during lysosomal exocytosis [J].
Jaiswal, JK ;
Chakrabarti, S ;
Andrews, NW ;
Simon, SM .
PLOS BIOLOGY, 2004, 2 (08) :1224-1232